German $10 bln publisher IPO is buyout exit test
The author is a Reuters Breakingviews columnist. The opinions expressed are her own.
By Yawen Chen
LONDON, Sept 12 (Reuters Breakingviews) -Springer Nature’s fourth attempt at going public will set the bar for buyout barons stuck on the way out. The German academic research publisher on Thursday announced its intention to float in Frankfurt, over a decade after private equity owner BC Partners bought in. The risk is the initial public offering sweeteners prove insufficient to convince cautious investors staring at the precarious German economy.
Springer Nature’s path out of private ownership has been rocky. The company had to scrap its last listing attempt in 2020, which ambitiously sought to raise nearly 1 billion euros ($1.1 billion) during Covid-19. There were also fears that increasingly popular open-access journals would erode revenue from expensive subscriptions. The company eventually had to resort to a private change of hands in 2021 between funds controlled by BC Partners, which holds a 47% stake.
This time around, Springer Nature looks less dog-eared. The open-access model still means it collects fees from universities and research institutes. Adjusted revenue grew 5% last year, and operating profit has inched up by 1 percentage point annually since 2019. As a result, Springer Nature’s much-frowned debt burden has more than halved to 2.7 times EBITDA. Prospective IPO investors will get an annual dividend equaling 50% of adjusted net income on a permanent basis.
As such, there’s a way for the group to be worth 9 billion euros ($10 billion), as bankers hope. In 2023 Springer Nature made around 685 million euros of EBITDA, Breakingviews calculates from conversations with a source familiar with the situation. On a multiple of 16 – the average of rivals Wiley WLY.N, Wolters Kluwer WLSNc.AS, RELX REL.L and Informa INF.L – it would be worth 9.1 billion euros, after stripping out 1.85 billion euros of net debt.
Yet that ignores the need for a discount for factors such as Springer Nature’s relatively higher leverage to its peer group. The research publishing sector is also only expected to grow at a compound annual growth rate of around 3% between 2023 and 2029. And IPO markets are moribund – in the first half they raised their lowest volume since 2016, Dealogic data shows.
Either way buyout shops are sitting on more than $3 trillion of portfolio companies, and have held onto them for an uncomfortably long median of over five years, per research shop Preqin. Springer Nature could raise its chances of success via a smaller fund-raising target of around 500 million euros. If a float can get away at the desired valuation level, it will give some glum private equity types some reason to be cheerful.
Follow @ywchen1 on X
CONTEXT NEWS
Springer Nature said on Sept. 12 it plans to launch an initial public offering (IPO) on the Frankfurt Stock Exchange that could be completed by the end of 2024.
The company said its planned IPO will consist of a 200-million-euro ($220 million) capital increase and a sale of existing shares. It intends to pay a dividend of 25 million euros ($27.5 million) for this year, and thereafter an annual dividend of around 50% of annual adjusted net income.
Holtzbrinck Publishing Group and BC Partners currently own 53% and 47% stakes respectively.
Reuters reported in February an IPO could value the company at up to 9 billion euros including debt.
IPOs have been broadly lagging stock markets https://reut.rs/4gpP3De
Editing by George Hay and Streisand Neto
Aloqador aktivlar
Eng oxirgi yangiliklar
Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.
Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi
Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.
